MedPath
FDA Approval

Gemfibrozil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 24, 2015
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Gemfibrozil(600 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Blenheim Pharmacal, Inc.

171434587

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Blenheim Pharmacal, Inc.

Blenheim Pharmacal, Inc.

Blenheim Pharmacal, Inc.

171434587

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Gemfibrozil

Product Details

NDC Product Code
10544-569
Application Number
ANDA074270
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 24, 2015
HYDROXYPROPYL CELLULOSE (TYPE H)Inactive
Code: RFW2ET671PClass: IACT
CALCIUM STEARATEInactive
Code: 776XM7047LClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
Code: Q8X02027X3Class: ACTIBQuantity: 600 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath